Regarding the genetic predisposition to MASLD-associated HCC, variations in several genes, including patatin-like phospholipase domain-containing protein 3 (PNPLA3), have been reported to be associated with the natural history of MASLD, including HCC development [17]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.